The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

BACKGROUND: Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics challenges, which makes optimizing vancomycin in this population cumbersome. Data are scarce on the clinical impact of time to therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Alshaya, Abdulrahman, Aljuhani, Ohoud, Alsaeed, Amjad, Alshehri, Nadiyah, Vishwakarma, Ramesh, Alzahrani, Hamdan, Althewaibi, Sara, Alghamdi, Nawaf, Alhelal, Khalid, Alharbi, Aisha, Al Harbi, Shmeylan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613993/
https://www.ncbi.nlm.nih.gov/pubmed/34819023
http://dx.doi.org/10.1186/s12879-021-06840-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613993/
https://www.ncbi.nlm.nih.gov/pubmed/34819023
http://dx.doi.org/10.1186/s12879-021-06840-y

Ejemplares similares